Session 56 - Antibiotics

Saturday, June 16 (12:45 PM - 2:15 PM), Poster & Exhibition Area

 
 

Abstract Title

56.001 Survey role and important of surfaces structureand β-lactamase of Bacillus cereus in drug resistance
56.003 High prevalence of multidrug resistant bacterial infections in Nepalese patients.
56.004 Antimicrobial susceptibility pattern of Gram negative bacterial isolates from urine in tertiary care hospital of Eastern Nepal
56.005 Extended spectrum beta-lactamases in urinary isolates of Escherichia coli in five Iranian hospitals
56.006 Very low rate of antibiotic resistance among HIV positive children in Kyrgyzstan compared to those from Cambodia
56.007 Resistance of strains S. epidermidis, isolated from patients with knee or hip joint replacement
56.008 Methicillin-resistant staphylococci from pigs in Nsukka agricultural zone of Enugu State, Nigeria: occurrence, species distribution antimicrobial resistance profile and virulence traits
56.009 Susceptibility of group A Streptococcus to antimicrobial agents – a surveillance study
56.010 Multidrug resistant Escherichia coli isolated from urinary tract infections in a tertiary care hospital, Bangalore, South India
56.011 A clinco-microbiological profile of carbapenem resistance among nosocomial infections in a tertiary care hospital
56.012 Virulence characteristics and antibiotic resistance among Enterococci isolated from Bagan Lalang beach, Malaysia
56.013 Antimicrobial resistance in neonatal septicaemia:  A therapeutic challenge to Pediatricians of rural India
56.014 Thermally injured and Acinetobacter baumannii colonizations/infections during a five-year period at the Brussels Burn Wound Centre
56.015 Comparison of tigecycline tolerance amongst clinical and hospital environment isolates of Acinetobacter baumannii
56.016 Prevalence of OXA-2 and OXA-10 type ESBL and class I integron among Acinetobacter bumanii strains isolated from patients in Tabriz–North West Iran
56.017 Frequency and molecular characterization of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in neonatal sepsis, Peru
56.018 Activity of cefaperazone-sulbactam against gram negative bacilli
56.019 Characterization of carbapenemase producing Enterobacteriaceae
56.020 Comparison of nasal carriage of Staphylococcus aureus and its antimicrobial resistance in various grades of medical students
56.021 Trend of penicillin-resistant Streptococcus pneumoniae in a tertiary teaching hospital in Malaysia
56.022 Multilocus sequence typing of clinical ESBL- producing E. coli strains
56.023 Synergistic effects of sodium chenodeoxycholic acid on antimicrobial activities of β-lactam antibiotics against β-lactamase-producing Staphylococcus aureus
56.024 In vitro neuraminidase inhibitory activities of four neuraminidase inhibitors against influenza viruses isolated in the 2010-2011 and 2011-2012 influenza seasons in Japan
56.025 Trends in antimicrobial susceptibility among bacterial isolates from urinary tract infections in Japanese hospitals participating in the Levofloxacin Surveillance Group during the period 1994-2010
56.026 Antimicrobial susceptibility pattern of Neisseria gonorrhoea isolates in northeastern Malaysia
56.027 Evaluation of antimicrobial susceptibility of gram negative bacilli isolated from nosocomial infection in general hospital Tehran, Iran 2011
56.028 Occurence of vancomycin-resistant Enterococcus faecium in patient isolates and aquatic environment during a period between 2004 and 2010
56.029 Frequency and anti-biogram pattern of enterococci species isolated from various clinical samples in Shahid Mohammadi Hospital, Bandar-Abbas, Iran
56.030 Antibiotic resistance of Pseudomonas aeruginosa clinical isolates from Greece and Romania during the year 2009
56.031 Current status of Glycopeptide intermediate and heterogenous Glycopeptide intermediate Staphylococcus aureus and their prevailing susceptibility pattern at two tertiary care hospitals of Pakistan
56.032 Possible antagonism with use of ceftaroline and rifampin to treat methicillin-resistant Staphylococcus aureus infection
56.033 In vitro antimicrobial activity of colistin in combination with rifampicin against carbapenem-resistant Acinetobacter baumannii
56.034 Antibiotic resistance profiles of Staphylococcus aureus bloodstream isolates
56.035 Spectrum of causative agents of nosocomial infections (NI) and their susceptibility to antimicrobials (AM) in multiward clinical hospital: results of one-year surveillance study
56.036 Detection of integron elements and gene groups encoding ESBLs and their prevalence in E.coli and Klebsiella isolated from urine samples by PCR method
56.037 Prevalence of extended spectrum β-lactamases (ESBLs), AmpC, Carbapenemases and New Delhi metallo-beta-lactamase (NDM) among 869 blood stream (BS) isolates of Enterobacteriaceae obtained from five Indian Hospitals during 2007 – 2010
56.038 Prevalence and antibiotic susceptibility pattern of community acquired methicillin resistant Staphylococcus aureus isolates in an intensive care unit in Saudi Arabia
56.039 Antibiotic susceptibility profiles of clinical isolates of Acinetobacter species isolated from Selayang hospital, Malaysia
56.040 The distribution of blaSHV, blaTEM and blaCTX-M genes in Klebsiella pneumoniae and Escherichiae coli clinical isolates at a tertiary hospital in South Africa
56.041 Antimicrobial resistance trends in blood culture positive Salmonella Paratyphi A isolates from Pondicherry, India, 2005 - 2009
56.042 Extended-spectrum beta-lactamase and metallo-beta-lactamase-producing bacterial strains among the patients attending a tertiary care center in Nepal
56.043 Identification of mecA genes in environmental Staphylococcal isolates
56.044 Staphylococcal cassette chroromosome mec (SCCmec) typing of methicillin-resistant Staphylococcus aureus (MRSA) isolates from patients attending Tengku Ampuan Afzan hospital (HTAA) in Kuantan, Pahang, Malaysia
56.045 'MIC-Creep' in Clostridium difficile?
56.046 Enteric fever in Cambodian children is dominated by multidrug resistant H58 Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin
56.047 Antimicrobial susceptibility pattern of Pseudomonas aeruginosa isolated  in Surgical patients: evaluation challenge from Kigali University Teaching Hospital
56.048 Trends and pattern of antimicrobial resistance among blood culture isolates of selected bacterial pathogens in South Africa, 2005-2009
56.049 Trends in antimicrobial susceptibility of Pseudomonas aeruginosa isolates from urinary tract and respiratory tract infections in Japanese hospitals participating in the Levofloxacin Surveillance Group during the period 1994-2010
56.051 Susceptibility of antibiotics for infected Burkholderia pseudomallei patients found in Sapprasithiprasong Hospital
56.052 Assessment of antibacterial activity of silver ions in infected diabetic foot ulcers - an answer to antibiotic resistance
56.053 Bacterial biofilms: exploring the emerging link in pathogenesis and therapeutic implications among multidrug resistant bacterial isolates
56.054 Aminoglycoside resistance in clinical isolates of Gram negative bacilli encountered over a period of 30 years at the University Hospital of the West Indies, Jamaica
56.055 Genotypic Distribution of Plasmid Encoded Extended Spectrum Beta-lactamases from Lahore, Pakistan
56.056 New Delhi metallo-β-lactamase-1 (NDM-1)-producing Enterobacteriaceae: first report in Thailand
56.057 Detection of CTX-M type Extended Spectrum Beta Lactamase genes among gram-negative clinical strains isolated from a tertiary care hospital, Mangalore (Karnataka, S.India)
56.058 Antimicrobial susceptibility and resistant integron of Klebsiella oxytoca isolates in Russia
56.059 Clinico-epidemiologic and molecular characterization of vancomycin resistant Enterococci (VRE) isolated from patients with end stage renal disease in south India
56.060 Determination of colistin resistance mechanism of Acinetobacter baumannii isolated in Siriraj Hospital, Thailand
56.061 Molecular epidemiology of Acinetobacter baumannii integrated with genomic resistance island
56.062 The detection of the NDM-1 and other carbapenemase genes in multidrug resistant Gram negative bacilli (MDRGNB) in a Jamaican hospital
56.063 High prevalence of D-test positivity in clinical isolates of Staphylococcus aureus among Japanese children
56.064 Survey for carbapenemase-producing Klebsiella pneumoniae isolated from clinical specimens in Thai hospitals
56.065 Individual-based simulations for malaria
56.066 New variant of an imipenemase, IMP-32, in a Klebsiella pneumoniae from a fatal case of Thai patient
56.067 Staphylococcus aureus blood stream infections in Cambodian adults
56.068 Genotypic characterization of antiviral susceptibility of Influenza A viruses isolated in Kenya from 2008 to 2011
56.069 Fluoroquinolone resistance via qnrA integron cassette in ESBL producing Escherichia coli clinical isolates from Thailand
56.070 Trends in antimicrobial susceptibility among bacterial isolates from respiratory tract infections in Japanese hospitals participating in the Levofloxacin Surveillance Group during the period 1994-2010
56.071 Anti-Brucella activity of Moringa oleifera in vitro against Brucella abortus
56.072 Biapenem for community-acquired pneumonia in elderly patients
56.073 Treatment efficacy of 3-day or 7-day administration of faropenem sodium for acute uncomplicated cystitis
56.074 Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae: Implications of Ertapenem susceptibility
56.075 Randomized clinical trial of mebendazole, metronidazol and praziquantle in the treatment of giardiasis in Islamic Republic of Iran 2008  
56.076 Mangosteen spray for efficacious treatment of streptococcal pharyngitis
56.077 Rationalizing the use use of Linezolid through Antibiotic Stewardship program in a tertiary care teaching hospital in Pakistan
56.078 Antibiotics use pattern and knowledge of antibiotics resistance among undergraduates in a Nigerian university
56.079 Improving outcomes in the treatment of cellulitis
56.080 The evaluation of safety and efficacy of Teicoplanin (Targocid R) therapy with Rifampin, Ciprofloxacin in 50 patients with osteomyelitis
56.081 Pattern of antibiotic usage for treatment of methicillin resistant Staphylococcus aureus infections and their outcomes at a tertiary care hospital in Springfield, Illinois
56.082 Bacteriophages – alternative approach to treat infections caused by bacterial pathogens
56.083 Impact of inappropriate empiric antimicrobial therapy on mortality of septic patients with bacteremia: a retrospective study
56.084 A multidisciplinary approach to antimicrobial stewardship: taking advantage of information systems technology
56.085 Evaluation of vancomycin dosing in overweight and obese patients with a creatinine clearance less than 60 milliliters per minute 
56.086 Ignorance: a blessing or a curse-awareness among Indian physicians on NDM-1 and its impact on antibiotic selection
56.087 Impact of dedicated clinicians on the outcomes of an immediate concurrent feedback antimicrobial stewardship program in a hematology-oncology unit
   
   


International Society for Infectious Diseases
9 Babcock Street, Unit 3, Brookline MA 02446-5903 · USA
Phone: (617) 277-0551      ·      Fax: (617) 278-9113 · info@isid.org

© 2001-2010 International Society for Infectious Diseases. All Rights Reserved.
 


CD-ROM Produced by X-CD Technologies